Arsenic and white blood cell count decreased Patient Reports February 12, 2012

Arsenic Side Effects Report #5907484-8
Arsenic side effect was reported by a Physician from ITALY on Sept 22, 2008. Male patient, 67 years of age, weighting 136.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: bronchopneumonia, haemoglobin decreased, neutrophil percentage decreased, platelet count decreased, respiratory depression, white blood cell count decreased. Arsenic dosage: 15 MG TWO TIMES PER WEEK (3 CYCLES) INTRAVENOUS DRIP. During the same period patient was treated with ARSENIC TRIOXIDE, ZELITREX, POTASSIUM CHLORIDE, MAG. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #4867036-8
Arsenic side effect was reported by a Health Professional from JAPAN on Dec 08, 2005. Female patient, 76 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: white blood cell count decreased. Arsenic dosage: 9.225 MG DAILY INTRAVENOUS DRIP. During the same period patient was treated with BROTIZOLAM, WARFARIN POTASSIUM, AMLODIPINE BESYLATE, SENNA LEAF, VALSARTAN. Patient recovered.

Arsenic Side Effects Report #4940793-8
Arsenic side effect was reported by a Physician from JAPAN on Feb 21, 2006. Male patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, disseminated intravascular coagulation, gamma-glutamyltransferase increased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Arsenic dosage: 9.3 MG QD INTRAVENOUS DRIP. During the same period patient was treated with NAFAMOSTAT MESILATE. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #5062933-5
Arsenic side effect was reported by a Physician from JAPAN on July 11, 2006. Male patient, 51 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: eosinophil count increased, white blood cell count decreased. Arsenic dosage: 10.725 MG QD INTRAVENOUS DRIP. During the same period patient was treated with ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, IDARUBICIN, GABEXATE MESILATE, DANAPAROID, FLOMOXEF, ISEPAMICIN SULPHATE. Patient was hospitalized. Patient recovered.


Arsenic Side Effects Report #4947901-3
Arsenic side effect was reported by a Physician from JAPAN on Mar 01, 2006. Male patient, 51 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: white blood cell count decreased. Arsenic dosage: 10.725 MG QD INTRAVENOUS DRIP. During the same period patient was treated with ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, IDARUBICIN, GABEXATE MESILATE, DANAPAROID, FLOMOXEF, ISEPAMICIN SULPHATE, CEFTAZIDIME. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #4963786-3
Arsenic side effect was reported by a Physician from JAPAN on Mar 22, 2006. Male patient, 51 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: white blood cell count decreased. Arsenic dosage: 10.725 MG QD INTRAVENOUS DRIP. During the same period patient was treated with ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, IDARUBICIN, GABEXATE MESILATE, DANAPAROID, FLOMOXEF, ISEPAMICIN SULPHATE, CEFTAZIDIME. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #5646733-0
Arsenic side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 20, 2008. Female patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: brain herniation, haemoglobin decreased, hydrocephalus , platelet count abnormal, subdural haemorrhage, white blood cell count decreased. Arsenic dosage: unknown. During the same period patient was treated with CYTARABINE. Patient recovered.